Clinical Prognostic Factors in Malignant Parotid Gland Tumors

OBJECTIVE: To analyze the factors in parotid malignant epithelial tumors influencing recurrences and disease-specific survival. METHODS: We retrospectively reviewed the files of 150 patients treated at our institution, from 1974 to 1998. Twenty-four patients were not treated by surgery and were excluded from this study. The remaining 126 patients were treated with surgery and 74 patients had postoperative radiotherapy. Thirty-three patients were treated with parotidectomy plus neck dissection. Neck lymph node metastasis was found in 22 patients, 5 patients had occult neck metastasis, and 4 periparotid lymph nodes metastasis. The mean age was 49 years old. According to the UICC/1997 TNM Classification, 49 patients were stage I, 27 stage II, 22 stage III, and 28 stage IV. The influence of selected factors on the 10 year disease-specific survival was analyzed using the Kaplan-Meier actuarial method and the log-rank test. RESULTS: Forty patients had mucoepidermoid carcinoma, 18 patients adenocarcinoma NOS, 18 patients acinic cell carcinoma, 15 patients adenoid cystic carcinoma, 11 patients malignant mixed tumor, 11 patients salivary duct carcinoma, and 13 patients other pathology. Twenty-five patients had recurrences: 17 had local recurrences, 4 patients had neck recurrences, and 4 were loco-regional recurrences. Five factors influenced negatively the prognosis: 1) T stage (p.00001), 2) grade (p.00001), 3) + lymph nodes (p.0007), 4) facial nerve dysfunction (p.0001), and 5) age (p.004). Patients with high-grade tumors and high-stage tumors had the worst prognosis according to the multivariate analysis. The 10-year disease-specific survival was 97% for stage I, 81% for stage II, 56% for stage III, and 20% for stage IV. CONCLUSION: The grade of the tumor and stage were the most important prognostic factor.

[1]  L. Kowalski,et al.  Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. , 2001, Archives of otolaryngology--head & neck surgery.

[2]  S. Rybakov,et al.  [Classification of malignant tumors of suprarenal glands]. , 2004, Klinichna khirurhiia.

[3]  R. Spiro,et al.  Stage means more than grade in adenoid cystic carcinoma. , 1992, American journal of surgery.

[4]  R. Spiro,et al.  Cancer of the parotid gland. A clinicopathologic study of 288 primary cases. , 1975, American journal of surgery.

[5]  Christian Godballe,et al.  Parotid Carcinoma: Impact of Clinical Factors on Prognosis in a Histologically Revised Series , 2003, The Laryngoscope.

[6]  P. Zbären,et al.  Elective neck dissection versus observation in primary parotid carcinoma , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[7]  A. Franchi,et al.  Risk factors for distant metastases from carcinoma of the parotid gland , 1997, Cancer.

[8]  R. Spiro,et al.  The indications for elective treatment of the neck in cancer of the major salivary glands , 1992, Cancer.

[9]  J. Medina.  Neck dissection in the treatment of cancer of major salivary glands. , 1998, Otolaryngologic clinics of North America.

[10]  O. Guntinas-Lichius,et al.  High incidence of lymph node metastasis in major salivary gland cancer. , 2003, Archives of otolaryngology--head & neck surgery.

[11]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[12]  E. Hjørting-Hansen.  Classification of malignant tumors , 1979 .

[13]  O. F. Storchi,et al.  Parotid Gland Carcinoma: Analysis of Prognostic Factors , 1998, The Annals of otology, rhinology, and laryngology.

[14]  L. Sobin,et al.  TNM classification of malignant tumors, fifth edition (1997) , 1997, Cancer.

[15]  M. Therkildsen,et al.  Salivary gland carcinomas--prognostic factors. , 1998, Acta oncologica.

[16]  R. Spiro,et al.  Management of the neck in parotid carcinoma. , 1996, American journal of surgery.

[17]  M. McGurk,et al.  Clinico-pathological and treatment-related factors influencing survival in parotid cancer , 1999, British Journal of Cancer.

[18]  K. Olsen,et al.  Primary parotid malignancies. A clinical and pathologic review. , 1991, Archives of otolaryngology--head & neck surgery.

[19]  D.,et al.  Regression Models and Life-Tables , 2022 .

[20]  A. A. Hart,et al.  The development of a prognostic score for patients with parotid carcinoma , 1999, Cancer.

[21]  J. Overgaard,et al.  Malignant parotid tumors in 110 consecutive patients: Treatment results and prognosis , 1992, The Laryngoscope.

[22]  R. Häusler,et al.  [Carcinoma of the parotid gland]. , 2003, Xianggang hu li za zhi. The Hong Kong nursing journal.

[23]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[24]  J. Eveson,et al.  WHO International Histological Classification of Tumours. Tentative Histological Classification of Salivary Gland Tumours. , 1990, Pathology, research and practice.

[25]  R. Orecchia,et al.  Treatment of malignant neoplasms of the parotid gland , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[26]  R. Spiro,et al.  Salivary gland tumors. , 1990, Current opinion in oncology.

[27]  A. Shaha,et al.  Management of Clinically Negative Cervical Lymph Nodes in Patients with Malignant Neoplasms of the Parotid Gland , 2001, ORL.

[28]  K. Ang,et al.  Prognostic variables in parotid gland cancer. , 1991, Archives of otolaryngology--head & neck surgery.

[29]  J. Overgaard,et al.  Prognostic indicators for malignant tumours of the parotid gland. , 2002, Clinical otolaryngology and allied sciences.

[30]  Hyun-Yong Lee,et al.  Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. , 2001, Archives of otolaryngology--head & neck surgery.